AJP Rep 2016; 06(02): e160-e164
DOI: 10.1055/s-0036-1582136
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnosing Pulmonary Embolism in Pregnancy: Are Biomarkers and Clinical Predictive Models Useful?

Barbara V. Parilla
1   Department of Obstetrics and Gynecology, Advocate Lutheran General Hospital, Park Ridge, Illinois
,
Rachel Fournogerakis
1   Department of Obstetrics and Gynecology, Advocate Lutheran General Hospital, Park Ridge, Illinois
,
Amy Archer
2   Department of Emergency Medicine, Advocate Lutheran General Hospital, Park Ridge, Illinois
,
Suela Sulo
3   James R. & Helen D. Russell Institute for Research & Innovation, Advocate Lutheran General Hospital, Park Ridge, Illinois
,
Lisa Laurent
4   Department of Radiology, Advocate Lutheran General Hospital, Park Ridge, Illinois
,
Patricia Lee
5   Department of Emergency Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois
,
Benazir Chhotani
5   Department of Emergency Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois
,
Kathleen Hesse
6   Department of Emergency Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois
,
Erik Kulstad
6   Department of Emergency Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois
› Author Affiliations
Further Information

Publication History

18 February 2016

25 February 2016

Publication Date:
25 April 2016 (online)

Abstract

Objective The objective of this study was to evaluate whether trimester-specific D-dimer levels or the modified Wells score (MWS) is a useful risk stratification tool to exclude pregnant women at low risk of pulmonary embolism (PE) from diagnostic imaging.

Study Design This is a prospective and retrospective cohort study. Pregnant women who underwent diagnostic imaging for suspected PE were prospectively enrolled. D-dimer serum levels were drawn, and a MWS was assigned. Pregnant women diagnosed with a PE before study launch who underwent diagnostic imaging and had a D-dimer level drawn were also evaluated.

Results In this study, 17 patients were diagnosed with a PE and 42 patients had no PE on diagnostic imaging. Sixteen out of 17 patients with a PE versus 11 out of 42 without PE had an abnormal D-dimer level (p = 0.001). Four patients with a PE versus zero without a PE had an abnormal MWS (p = 0.005). The combination of a trimester-specific D-dimer level along with the MWS was abnormal in all 17 patients with a documented PE versus 11/42 (26.2%) patients without a documented PE (p = 0.001).

Conclusion A combination of trimester-specific D-dimer levels along with a MWS can be used in pregnancy to triage women into a low-risk category for PE and thereby avoid radiation exposure in a majority of pregnant patients.

Note

Registered with clinicaltrials.gov # NCT02709174.


 
  • References

  • 1 O'Connor C, Moriarty J, Walsh J, Murray J, Coulter-Smith S, Boyd W. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. J Matern Fetal Neonatal Med 2011; 24 (12) 1461-1464
  • 2 Wells PS, Hirsh J, Anderson DR , et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345 (8961) 1326-1330
  • 3 Wells PS, Anderson DR, Rodger M , et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001; 135 (2) 98-107
  • 4 Cutts BA, Tran HA, Merriman E , et al. The utility of the Wells clinical prediction model and ventilation-perfusion scanning for pulmonary embolism diagnosis in pregnancy. Blood Coagul Fibrinolysis 2014; 25 (4) 375-378
  • 5 Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 2005; 51 (5) 825-829
  • 6 Chan WS, Lee A, Spencer FA , et al. D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost 2010; 8 (5) 1004-1011
  • 7 Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009; 114 (6) 1326-1331
  • 8 Tanous D, Siu SC, Mason J , et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010; 56 (15) 1247-1253
  • 9 Winkler BE, Schuetz W, Froeba G, Muth CM. N-terminal prohormone of brain natriuretic peptide: a useful tool for the detection of acute pulmonary artery embolism in post-surgical patients. Br J Anaesth 2012; 109 (6) 907-910
  • 10 Coutance G, Le Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care 2008; 12 (4) R109
  • 11 Kline JA, Richardson DM, Than MP, Penaloza A, Roy PM. Systematic review and meta-analysis of pregnant patients investigated for suspected pulmonary embolism in the emergency department. Acad Emerg Med 2014; 21 (9) 949-959